Patents by Inventor Richard Kuo

Richard Kuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7131071
    Abstract: A facility for defining a process for approving requests for approval of a selected type is described. The facility displays a palette containing visual representations of each of a plurality of approval process elements. The facility then receives a number of user input instances, each user input instance dragging one of the visual representations into a selected location in a workspace, so as to form an arrangement of approval process elements. The facility then stores a process definition corresponding to the formed arrangement of approval process elements.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: October 31, 2006
    Assignee: Siebel Systems, Inc.
    Inventors: Prasad Gune, Anthony Deighton, Mingte Chen, Richard Kuo, Wister Walcott
  • Publication number: 20060063219
    Abstract: An in vitro protein kinase assay technology that (1) exhibits a high assay signal to background ratio (S/B) and range (S-B); (2) is homogenous; (3) is non-radioactive; and (4) does not require a phospho-specific antibody involves complexing a trivalent metal ion (e.g. Ga3+, Fe3+, Al3+, In3+, Ru3+, Sc3+, Y3+) to the surface of amplified luminescent proximity assay acceptor or donor beads, e.g., via a suitable linker such as nitrilotriacetic acid (NTA; also referred to as carboxymethyl-lysine), iminodiacetic acid (IDA), or an appropriately substituted N-containing heterocycle, for example a triazoheterocycle, for example a triazocyclononaneononane, such as 1-propylamino-4-acetato-1,4,7-triazacyclononane. A protein (or constituent part) or other kinase substrate is bound to the surface of the other of an amplified luminescent proximity assay acceptor or donor bead and, if phosphorylated, brought into proximity with the trivalent metal ion-complexed acceptor bead to generate a luminescent signal.
    Type: Application
    Filed: September 19, 2005
    Publication date: March 23, 2006
    Inventors: Richard Kuo, Timothy Dawes, Timothy Machajewski
  • Publication number: 20060046002
    Abstract: A tamper-indicating printable sheet. A preferred embodiment of the invention provides a tamper-indicating printable sheet comprising a retroreflective layer comprising a plurality of microbeads partially embedded in an inkjet receptive beadbond layer; and a reflector layer between one of the microbeads and the inkjet receptive beadbond layer. The present invention provides a method of making a tamper-indicating printable sheet.
    Type: Application
    Filed: August 3, 2005
    Publication date: March 2, 2006
    Inventors: Richard Kuo, Mathias Detjen, Brian Dunne, Paul Marecki, Tadesse Nigatu, Kenneth White
  • Publication number: 20060029753
    Abstract: A tamper-indicating printable sheet. A preferred embodiment of the invention provides a tamper-indicating printable sheet comprising a retroreflective layer comprising a plurality of microbeads partially embedded in an inkjet receptive beadbond layer; and a reflector layer between one of the microbeads and the inkjet receptive beadbond layer. The present invention provides a method of making a tamper-indicating printable sheet.
    Type: Application
    Filed: August 6, 2004
    Publication date: February 9, 2006
    Inventors: Richard Kuo, Mathias Detjen
  • Patent number: 6737272
    Abstract: Nitric oxide synthase and nitric-oxide-related bioactivity are shown to be necessary and sufficient for activation of an oocyte during the process of fertilization. Methods are provided for the modulation of oocyte activation through modulation of nitric oxide levels. Oocyte activation is enhanced by the addition of nitric oxide synthase, nitric oxide synthase activators, nitric oxide donors, or other compounds that increase the nitric oxide levels of the oocyte during fertilization. The administration of NOS inhibitors is used to block oocyte activation, where contraception is desired.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: May 18, 2004
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Cornell Research Foundation, Inc.
    Inventors: Richard Kuo, Gregory Baxter, David Epel
  • Publication number: 20030204427
    Abstract: A facility for presenting approval requests is described. The facility simultaneously displays information describing both a first approval request and a second approval request, where the first approval request is generated using a first application program, and the second approval request is generated using a second application program that is distinct from the first application program.
    Type: Application
    Filed: March 29, 2002
    Publication date: October 30, 2003
    Inventors: Prasad Gune, Anthony Deighton, Mingte Chen, Richard Kuo, Wister Walcott
  • Publication number: 20030189600
    Abstract: A facility for defining a process for approving requests for approval of a selected type is described. The facility displays a palette containing visual representations of each of a plurality of approval process elements. The facility then receives a number of user input instances, each user input instance dragging one of the visual representations into a selected location in a workspace, so as to form an arrangement of approval process elements. The facility then stores a process definition corresponding to the formed arrangement of approval process elements.
    Type: Application
    Filed: March 29, 2002
    Publication date: October 9, 2003
    Inventors: Prasad Gune, Anthony Deighton, Mingte Chen, Richard Kuo, Wister Walcott
  • Publication number: 20020106360
    Abstract: Nitric oxide synthase and nitric-oxide-related bioactivity are shown to be necessary and sufficient for activation of an oocyte during the process of fertilization. Methods are provided for the modulation of oocyte activation through modulation of nitric oxide levels. Oocyte activation is enhanced by the addition of nitric oxide synthase, nitric oxide synthase activators, nitric oxide donors, or other compounds that increase the nitric oxide levels of the oocyte during fertilization. The administration of NOS inhibitors is used to block oocyte activation, where contraception is desired.
    Type: Application
    Filed: December 8, 2000
    Publication date: August 8, 2002
    Applicant: BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY & CORNELL RESEARCH FOUNDATION INC
    Inventors: Richard Kuo, David Epel, Gregory Baxter